-
The collection of drugs into pharmacies has accelerated, and the retail industry has ushered in more opportunities
Time of Update: 2023-01-01
According to media reports, since the beginning of this year, 161 designated retail pharmacies in Xuzhou, Jiangsu Province have passed the acceptance inspection, covering 150 townships (streets) in the city, including 138 chain retail pharmacies and 23 single retail pharmacies.
-
Take the medical alliance as the carrier to do a good job in the graded diagnosis and treatment work plan of new coronary pneumonia
Time of Update: 2023-01-01
According to the website of the National Health Commission on December 7, the comprehensive group of the joint prevention and control mechanism of the State Council to respond to the new coronavirus
-
Interpretation of the policy of the Measures for Reporting Rewards for the Illegal Use of Medical Security Funds
Time of Update: 2023-01-01
Recently, the National Health Insurance Administration and the Ministry of Finance jointly formulated the Measures for Reporting Rewards for the Illegal Use of Medical Security Funds (hereinafter ref
-
From December 1, a large number of rare disease drugs and anticancer drugs will be reduced in taxes
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];Recently, the Ministry of Finance, the General Administration of Customs, the State Administration of Taxation and the State Food and Drug Administration jointly issued the Announcement on Issuing the Third Batch of Anti-Cancer Drugs and Rare Disease Drugs Subject to the VAT Policy (hereinafter referred to as the "Announcement").
-
Pharmaceutical companies are overbearing to eat KRAS G12C inhibitors, and a new round of tumor new drug racing has begun fiercely
Time of Update: 2023-01-01
In addition to the marketed Sotorasib, Mirati Therapeutics' Adagrasib (MRTX849) has submitted a new drug application to the US FDA; JDQ443 developed by Novartis is in phase III clinical trials for non-small cell lung cancer.
-
4 pharmaceutical companies have increased their annual results! 1 company's net profit is expected to increase by more than 100%
Time of Update: 2023-01-01
According to incomplete statistics, up to now, 5 pharmaceutical companies have issued annual performance forecasts, and 4 performance is expected to achieve growth, namely Dongxing Medical, Xintiandi, Huaxia Ophthalmology, and Jardine Jardine Jiaye, of which Jardine Jardine is expected to increase the net profit attributable to shareholders of listed companies by more than 100% in 2022.
-
How to do a good job in health protection for pregnant women and children Authoritative experts responded to epidemic prevention hot spots
Time of Update: 2023-01-01
Pregnant women need to pay attention to protection and do the following key points: wear masks when going out, wearing masks in public places, wearing N95 masks when visiting hospitals, and avoiding crowding places; Ventilate frequently at home or in the office to keep air circulating; Wash your hands frequently when you come back from outings.
-
CXO head companies have been reduced again, does the track still have development prospects?
Time of Update: 2023-01-01
On November 25, WuXi AppTec, a leading CXO company, announced that due to its own capital needs, the shareholders controlled by the actual controller of the company and the shareholders who signed a
-
All localities will accelerate the formulation of standards for traditional Chinese medicine formula granules, and pharmaceutical companies will usher in more challenges
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];Chinese medicine formula granules are granules made of single flavor Chinese medicine pieces by water extraction, separation, concentration, drying and granulation, under the guidance of Chinese medicine theory, according to the clinical prescription of Chinese medicine, can be used by patients, belonging to the management category of Chinese medicine pieces.
-
State Food and Drug Administration: From January 1, 2023, electronic declaration of drug registration applications will be implemented
Time of Update: 2023-01-01
2. The applicant shall prepare the electronic declaration materials in accordance with the current regulations and the requirements of electronic declaration materials, and submit the CD-ROM to the Drug Evaluation Center of the State Food and Drug Administration (hereinafter referred to as the Drug Review Center) for application.
-
New drugs for malaria! Novartis' novel combination therapy with MMV ganaplacide/lumefantrine-SDF will enter Phase 3 clinical development!
Time of Update: 2023-01-01
Nov. 25, 2022 /Biovalley BIOON/ -- Novartis and the non-profit organization Medicines for Malaria Venture (MMV) have jointly announced that the two parties have decided to advance ganaplacide/lumefantrine-solid dispersible (SDF) to Phase 3 clinical development as the threat of resistance to current antimalarial therapies increases.
-
Innovative drugs have both opportunities and challenges, and two core logics deserve attention
Time of Update: 2023-01-01
GF Securities also mentioned the above two types of enterprises, the bank pointed out that if Biotech truly becomes an international Big Pharma, its core is still to build product competitiveness, develop new drugs for unmet clinical needs, and also have global development and even commercialization capabilities.
-
The domestic AI pharmaceutical field is hot, attracting nearly 10 billion yuan in 2021
Time of Update: 2023-01-01
AI pharmaceuticals are different from traditional pharmaceuticals and are expected to break the dilemma that the average cost of new drug research and development exceeds US$1 billion and the R&D cycle is greater than 10 years, so it is highly expected by the industry.
-
There were 20 new investment and financing projects in the domestic medical and health field, and the field of medical devices and innovative drugs attracted strong funds
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];According to industry statistics, last week, a total of 20 domestic investment and financing projects in the medical and health field were included, including 7 and 6 investment and financing projects in the field of medical devices and innovative drugs.
-
High-risk classic Hodgkin lymphoma (cHL) first-line treatment! US FDA approves CD30-targeted drug Adcetris: treatment of pediatric patients aged ≥ 2 years old!
Time of Update: 2023-01-01
S. Food and Drug Administration (FDA) has approved CD30-targeted antibody drug conjugate (ADC) Adcetris (brentuximab vedotin, bentuximab for injection): plus standard of care dose intensive chemotherapy AVE-PC (doxorubicin, vincristine, etoposide, prednisone, cyclophosphamide) for the treatment of pediatric patients 2 years of age and older with previously untreated high-risk classical Hodgkin lymphoma (cHL).
-
"Green pharmaceutical" has become the focus of enterprise development, and a large number of pharmaceutical companies have been fined for environmental protection problems
Time of Update: 2023-01-01
Pharmaceutical manufacturing enterprises, especially chemical API enterprises, have a wide range of products, complex production processes, many types of raw materials, large quantities, low utilization rate of raw materials, so in recent years, with the continuous development and growth of the industry, its "three wastes" (waste liquid, waste gas, waste residue) are also causing more and more impact on human beings and the surrounding environment.
-
Daan Gene took the initiative to apply for a price reduction, or open a price war in the molecular diagnostic industry!
Time of Update: 2023-01-01
Recently, the centralized procurement platform for drugs and medical consumables in Gansu Province issued a notice that after receiving an application from an enterprise, 97 of the 53 registration certificates of the external diagnostic reagent products took the initiative to apply for a price reduction (Daan Gene), of which 12 new declaration registration certificates were reviewed and passed in accordance with the "green channel".
-
Good management practices for drug sales: quality management of drug retail distribution
Time of Update: 2023-01-01
Article 6: Pharmaceutical retail enterprises shall, in accordance with the relevant provisions of the Norms, formulate a quality management system for drug distribution, including personnel management, job responsibilities, facilities and equipment, operating procedures, records and vouchers, emergency management, and other such content, and periodically review and promptly revise them.
-
Good news has spread in the injection industry, and a number of new drugs have been approved for clinical trials
Time of Update: 2023-01-01
, a wholly-owned subsidiary of the company, has recently received the "Drug Registration Certificate" for ambroxol hydrochloride injection approved and issued by the State Medical Products Administration.
-
National Health Commission: Continue to increase the supervision of nucleic acid testing institutions
Time of Update: 2023-01-01
We have noticed that some places try to carry out nucleic acid self-collection in different forms, but special attention should be paid to the standardization, effectiveness and safety of self-collected nucleic acid, and a sound implementation plan should be formulated, and at the same time, it is necessary to do a good job in organizing implementation and strengthening technical guidance.
